Clinical Trial Update: Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating potential drug interaction between eltrombopag and lopinavir/ritonavir in healthy adult subjects. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Eltrombopag (eltrombopag)
• Kaletra (lopinavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED